Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Profit After Tax (2022 - 2025)

Historic Profit After Tax for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$10.4 million.

  • Lucid Diagnostics' Profit After Tax rose 1595.67% to -$10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.3 million, marking a year-over-year decrease of 1889.2%. This contributed to the annual value of -$45.5 million for FY2024, which is 1355.14% up from last year.
  • As of Q3 2025, Lucid Diagnostics' Profit After Tax stood at -$10.4 million, which was up 1595.67% from -$4.4 million recorded in Q2 2025.
  • Over the past 5 years, Lucid Diagnostics' Profit After Tax peaked at -$4.4 million during Q2 2025, and registered a low of -$26.9 million during Q1 2025.
  • For the 4-year period, Lucid Diagnostics' Profit After Tax averaged around -$13.1 million, with its median value being -$12.3 million (2022).
  • Data for Lucid Diagnostics' Profit After Tax shows a peak YoY increase of 5966.38% (in 2025) and a maximum YoY decrease of 15356.2% (in 2025) over the last 5 years.
  • Quarter analysis of 4 years shows Lucid Diagnostics' Profit After Tax stood at -$14.9 million in 2022, then grew by 27.45% to -$10.8 million in 2023, then dropped by 6.57% to -$11.5 million in 2024, then increased by 9.91% to -$10.4 million in 2025.
  • Its Profit After Tax stands at -$10.4 million for Q3 2025, versus -$4.4 million for Q2 2025 and -$26.9 million for Q1 2025.